St. Luke’s University Health Network (SLUHN) has been recognized as a 2026 HIMSS Davies Award of Excellence recipient for its innovative, technology-driven clinical transformation across multiple specialties. Through the integration of advanced predictive analytics, electronic health record (EHR) clinical decision support, and standardized multidisciplinary pathways, St. Luke’s has significantly improved patient outcomes, safety, and healthcare delivery across its network.

“No other health care organization in the world has won four Davies Awards. That distinction makes clear what our patients experience every day: St. Luke’s is setting the national standard for using innovation to deliver safer, smarter and more effective care,” said St. Luke’s Chief Information Officer Chad Brisendine.

Added St. Luke’s Chief Quality Officer Donna Sabol, “Our competitive advantage is not technology alone. It is our ability to combine technology, data and clinical expertise to achieve measurable results for the people and communities we serve."

"Winning once demonstrates innovation. Becoming the first organization in the world to win four times demonstrates a culture of continuous innovation,” Brisendine said. “This achievement reflects years of collaboration, trust and discipline among our clinical, operational, informatics and IT teams. Most importantly, it reflects their shared commitment to turning technology and data into better care for every patient.”

Serving communities across Pennsylvania and New Jersey, St. Luke’s University Health Network is a fully integrated, non-profit network providing care across multiple hospital campuses and outpatient sites. By leveraging digital solutions and data analytics, SLUHN has driven major improvements in inpatient deterioration prevention, antimicrobial stewardship, and behavioral health safety.

St. Luke’s University Health Network Davies Award Case Studies

Inpatient Deterioration: Deterioration Index (DI) Clinical Use Case

Outcomes:

• 25.8% reduction in codes per 1,000 discharges.
• 31.9% reduction in rapid response unanticipated ICU transfers.
• 55 additional lives saved over FY22–FY25.

Antimicrobial Stewardship: Optimizing Patient Outcomes via Innovative Vancomycin Therapeutic Drug Monitoring (TDM)

Outcomes:

• Nearly 60% relative risk reduction in vancomycin-induced Acute Kidney Injury (AKI).
• Estimated 2,022 nephrotoxic events prevented annually (~$16M in annual cost avoidance).

Behavioral Health & Patient Safety: Standardization of Suicide Risk Assessment and Risk-Aligned Interventions Across a Multisite Health Care Network

Outcomes:

• Increased adherence to risk-aligned observation from 50% to 73%.
• $2.93 million in total cost avoidance without compromising patient safety.

HIMSS Davies Award of Excellence

The HIMSS Davies Award of Excellence promotes HIMSS's vision and mission by recognizing and showcasing use cases, model practices, and lessons learned on how to improve health and wellness through the power of information and technology. Showcasing healthcare delivery systems worldwide, the Davies Award shares evidence-based case studies that drive the transformation of the global healthcare ecosystem.